III MultiMat

 III MultiMat (Almuñécar, 16-17/05/22) Enhanced antitumoral activity when combining PARP inhibitors with encapsulated BET inhibitors for the treatment of BRCA-mutated cancers (Oral presentation) María Arenas-Moreira, Alberto Juan, María de Mar Noblejas-López, Iván...